Trial Profile
Multi Center, Randomized, Double-blind, Placebo-controlled Parallel-group, Phase III Clinical Trial to Evaluate the Safety and Efficacy of PAC-14028 Cream in Mild to Moderate Atopic Dermatitis Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Oct 2021
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary)
- Indications Atopic dermatitis
- Focus Registrational; Therapeutic Use
- Acronyms CAPTAIN-AD
- Sponsors AmorePacific
- 01 Oct 2021 Primary endpoint (Success rate of Investigators Global Assessment (IGA)) has been met, according to Results published in the Journal of Allergy and Clinical Immunology.
- 01 Oct 2021 Results published in the Journal of Allergy and Clinical Immunology
- 18 Nov 2018 Status changed from active, no longer recruiting to completed.